Medtronic

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Medtronic 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About MDT

Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. It operates through the following segments: Cardiovascular Porrtfolio, Neuroscience Portfolio, Medical Surgical Portfolio, and Diabetes Operating Unit. 

CEO
Geoffrey Straub Martha
CEOGeoffrey Straub Martha
Employees
95,000
Employees95,000
Headquarters
Galway, Galway
HeadquartersGalway, Galway
Founded
2014
Founded2014
Employees
95,000
Employees95,000

MDT Key Statistics

Market cap
131.98B
Market cap131.98B
Price-Earnings ratio
27.81
Price-Earnings ratio27.81
Dividend yield
2.75%
Dividend yield2.75%
Average volume
8.98M
Average volume8.98M
High today
$104.50
High today$104.50
Low today
$101.98
Low today$101.98
Open price
$101.98
Open price$101.98
Volume
9.83M
Volume9.83M
52 Week high
$106.33
52 Week high$106.33
52 Week low
$79.55
52 Week low$79.55

Stock Snapshot

The current Medtronic(MDT) stock price is $103.88, with a market capitalization of 131.98B. The stock trades at a price-to-earnings (P/E) ratio of 27.81 and offers a dividend yield of 2.7%.

As of 2026-02-06, Medtronic(MDT) stock has fluctuated between $101.98 and $104.50. The current price stands at $103.88, placing the stock +1.9% above today's low and -0.6% off the high.

The Medtronic(MDT)'s current trading volume is 9.83M, compared to an average daily volume of 8.98M.

During the past year, Medtronic(MDT) stock moved between $79.55 at its lowest and $106.33 at its peak.

During the past year, Medtronic(MDT) stock moved between $79.55 at its lowest and $106.33 at its peak.

MDT News

Simply Wall St 1d
Is It Too Late To Consider Medtronic After Recent Share Price Gains?

If you are wondering whether Medtronic at around US$101.84 is still a solid deal or starting to look fully priced, this article is here to help you weigh up wha...

Is It Too Late To Consider Medtronic After Recent Share Price Gains?
TipRanks 2d
Micra AV Registry Reinforces Medtronic’s Leadless Pace

Medtronic (MDT) announced an update on their ongoing clinical study. Micra AV Post-Approval Registry shows Medtronic tracking long-term performance of its lead...

TipRanks 2d
Medtronic price target raised to $104 from $103 at UBS

UBS raised the firm’s price target on Medtronic (MDT) to $104 from $103 and keeps a Neutral rating on the shares. Published first on TheFly – the ultimate sour...

Analyst ratings

59%

of 32 ratings
Buy
59.4%
Hold
40.6%
Sell
0%

More MDT News

Benzinga 3d
Medtronic Bets On AI Heart Care With $585 Million Deal For Partner CathWorks

Medtronic plc (NYSE:MDT) on Tuesday announced it will exercise its option to acquire CathWorks, a privately held medical device company based in Israel. The ac...

Medtronic Bets On AI Heart Care With $585 Million Deal For Partner CathWorks
Reuters 3d
Medical device maker Medtronic to buy CathWorks in up to $585 million deal - Reuters

...

Medical device maker Medtronic to buy CathWorks in up to $585 million deal - Reuters
TipRanks 3d
Medtronic plans to acquire CathWorks

Medtronic (MDT) will exercise its option to acquire CathWorks, a privately held medical device company, which aims to transform how coronary artery disease is d...

Simply Wall St 3d
Does Expanded Medicare Access For MiniMed 780G Reshape The Bull Case For Medtronic?

In early February 2026, Medtronic reported three major U.S. milestones for its MiniMed 780G insulin delivery system, including Medicare access when paired with...

Does Expanded Medicare Access For MiniMed 780G Reshape The Bull Case For Medtronic?
TipRanks 4d
Medtronic announces three U.S. milestones related to MiniMed 780G

Medtronic (MDT) announced three significant U.S. milestones that expand access, choice, and flexibility for people living with type 1 and insulin-requiring type...

Simply Wall St 5d
Assessing Medtronic Valuation After Affera Deal And Cardiac Ablation Growth Outlook

Medtronic (MDT) is back in focus after recent analyst coverage spotlighted its Affera acquisition and the Cardiac Ablation Solutions segment, where the company...

Assessing Medtronic Valuation After Affera Deal And Cardiac Ablation Growth Outlook
TipRanks 7d
Medtronic resumed with an Overweight at Wells Fargo

Wells Fargo analyst Larry Biegelsen resumed coverage of Medtronic (MDT) with an Overweight rating and $114 price target The firm says Medtronic remains a top pi...

People also own

Based on the portfolios of people who own MDT. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.